These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 36837580)
1. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580 [No Abstract] [Full Text] [Related]
2. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution. Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204 [TBL] [Abstract][Full Text] [Related]
3. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging. Alreshq R; Cozzolino M; Lilleness B; Pipilas A; Mendelson L; Joshi T; Muralidhar V; Guardino E; Berk JL; Siddiqi OK; Gopal DM; Sanchorawala V; Ruberg FL Am J Cardiol; 2022 Oct; 181():105-112. PubMed ID: 36028388 [TBL] [Abstract][Full Text] [Related]
4. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era. Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490 [TBL] [Abstract][Full Text] [Related]
11. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis. Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779 [TBL] [Abstract][Full Text] [Related]
12. A case of disappearing amyloid on technetium pyrophosphate scan. Wang A; Mahmood U; Tang X; Jain D; Pan S J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232 [TBL] [Abstract][Full Text] [Related]
14. Standardization of Bokhari S; Morgenstern R; Weinberg R; Kinkhabwala M; Panagiotou D; Castano A; DeLuca A; Kontak A; Jin Z; Maurer MS J Nucl Cardiol; 2018 Feb; 25(1):181-190. PubMed ID: 27580616 [TBL] [Abstract][Full Text] [Related]
15. The use of PYP scan for evaluation of ATTR cardiac amyloidosis at a tertiary medical centre. Dower J; Dima D; Lalla M; Patel AR; Comenzo RL; Varga C Br J Cardiol; 2022; 29(2):19. PubMed ID: 36212788 [TBL] [Abstract][Full Text] [Related]
16. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study? Shen CP; Vanichsarn CT; Pandey AC; Billick K; Rubenson DS; Mohan RC; Heywood JT; Srivastava AV Int J Cardiovasc Imaging; 2023 Jan; 39(1):201-208. PubMed ID: 36598681 [TBL] [Abstract][Full Text] [Related]
17. Comparison of 1-h with 3-h planar Saitou T; Aikawa T; Manabe O; Nagase A; Kudo T; Oyama-Manabe N Ann Nucl Med; 2023 Feb; 37(2):99-107. PubMed ID: 36352186 [TBL] [Abstract][Full Text] [Related]